SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

September 08, 2010 08:15 ET

Letter to Stockholders of MMRGlobal, Inc.

LOS ANGELES, CA--(Marketwire - September 8, 2010) -  MMRGlobal, Inc. (OTCBB: MMRF) (

Dear Stockholder:

In my last letter to you, MMRGlobal (MMR) celebrated the launch of its new positioning and advertising campaign entitled "The Future Of Your Health At Work Today," and that is what has been happening over the summer. Your Company has continued a process of making the future of health care work for you.

  • We launched "The Future Of Your Health At Work Today" on the CBS Television broadcast of the Daytime Emmy Awards and, as part of that campaign, we built a lead capture tool with Lightbox displays. When a new visitor goes to the website, they are greeted with a Lightbox Promotion in the form of a check offering a $25 health rebate. The offer is featured in response to our advertising campaigns on Associated Television International (ATI) programming as well as on our radio campaign with Clear Channel Communications. These programs have already resulted in thousands of new visitors to our site to learn about the importance of having a Personal Health Record ( Our strategic relationship with ATI enables us to be viewed on major networks and cable channels such as ABC, CBS, Fox, NBC, The CW, USA, Discovery, Hallmark and The Travel Channel as a featured advertiser.
  • Since February 2008, MMR has been working with one of the largest financial institutions in the world on document delivery systems which are planned to be offered through our MyEsafeDepositBox platform ( We recently completed a two year process of becoming an approved vendor of the bank and are now working through the process of becoming a "current vendor." This demonstrates our ability to comply within a highly regulated banking environment and underscores the long lead times that are necessary to the sales of our products and services.
  • The Company is actively pursuing the patent restoration process for biotech assets acquired from the Company's merger with Favrille, specifically reviving selected patent applications related to making vaccines for treating B-cell pathologies and anti-CD20 monoclonal antibodies in countries of commercial interest. These countries include Australia, Brazil, Canada, China, India, Europe, Japan, Korea, Mexico, Hong Kong and Singapore. The Company has retained foreign associates for representation in all of these countries and has had various approvals of restoration resulting in pending patent applications in the majority of them, with the exception of Singapore and Hong Kong, where restoration approval is pending. The Company is also pursuing three additional patent applications specifically covering Favrille's B-cell vaccine technology and two patent applications related to anti-CD20 monoclonal antibodies in the United States. In May 2010, a Favrille B-cell patent was successfully revived and is issued in the United States.
  • We continue to work with The MichaelBass Group and are currently in various stages of due diligence on four possible acquisitions designed to expand the Company's product line and offer a wider selection of professional products and services. Any one of these four acquisitions could alter our guidance.

  • I will be a featured speaker at the Health Technology Investment Forum ( event on September 21, 2010 at the Westin Times Square in New York City, giving a company presentation to a group of 150 health care investors and executives. The conference is focused on private equity and institutional investors. Some of the institutional funds scheduled to participate this year are Camden Partners, Chrysalis Ventures, Needham & Company, Raymond James & Associates and Radius Ventures.

  • Kodak is in the process of launching a co-marketing and direct mail campaign featuring MMRGlobal and highlighting an MMRPro ( customer testimonial targeted to Kodak's document imaging and health care vertical. 
  • We formally launched an MMRGlobal Travel and Benefits Sales Group, which is being headed by Patrice A. Shilling. Patrice is a highly trained executive who has worked in senior management positions at Travelocity, American Express, Alitalia Airlines and Le Méridien and whose clients have included McKesson, Medtronic, Accenture, UBS, Boston Scientific and Liberty Mutual, amongst numerous other Fortune 500 and 1000 companies. We will discuss more about this in subsequent announcements, however, it can be said here that Patrice will focus on bringing our products and services to the travel and hospitality industry and corporate benefits channels, all of which represent the Company's highest gross margin products.

Prior to concluding, we would also like to update you on the use of the Company's equity line with Dutchess Opportunity Fund. Since October 13, 2009, when the Company first announced its relationship with Dutchess, the Company's stock has closed as high as $.32. Since that time, through yesterday's close, the Dow is up 5.8 percent, the Nasdaq is up 3.2 percent and the S&P 500 is up 1.8 percent while the Company's stock (MMRF) is up nearly 13 percent. In response to questions and comments from stockholders, there is no correlation between the Dutchess transaction and MMR's share price when looking at prices on a daily basis. Furthermore, between the effective date of the Dutchess transaction and yesterday's close, the Company has only sold 98,400 shares at a price of $.13 per share representing less than $14,000.

In closing, over the course of the summer, MMRGlobal continued to expand its footprint worldwide. As part of that process we are proud to announce a musical "logo" of the likes of Intel, Microsoft and NBC. Starting later this month, no matter where you are in the world, including China and India, you will hear the familiar sound of MMR representing safety and security when you access any one of our many websites. Hear it for yourself at and thank you for your interest and support of MMRGlobal.


Robert H. Lorsch
Chairman, President & Chief Executive Officer

About MMRGlobal, Inc.

MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit and view the videos at

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.'s business prospects, results of operations or financial condition, government regulation, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission.

Contact Information